EyePoint Pharmaceuticals, Inc. announced the appointment of Isabelle Lefebvre as Chief Regulatory Officer, succeeding John Weet, Ph.D., who will be leaving his role as Senior Vice President, Regulatory, following a transition period.
Company Information
Company
EyePoint Pharmaceuticals, Inc.
Location
480 PLEASANT STREET
Watertown, Massachusetts, United States
About
EyePoint Pharmaceuticals, Inc. is committed to developing and commercializing therapeutics to help improve the lives of patients with serious retinal diseases.
Fundz sees it the moment EyePoint Pharmaceuticals, Inc. changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
WatertownBiotechnologyHealthcareHealth CareTherapeuticsPharmaceutical